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Prenatal exposure to serotonin reuptake inhibitor (SRI) antidepressants and maternal
depression may affect prefrontal cognitive skills (executive functions; EFs) including
self-control, working memory and cognitive flexibility. We examined long-term effects of
prenatal SRI exposure on EFs to determine whether effects are moderated by maternal
mood and/or genetic variations in SLC6A4 (a gene that codes for the serotonin transporter
[5-HTT] central to the regulation of synaptic serotonin levels and behavior). Children who
were exposed to SRIs prenatally (SRI-exposed N = 26) and non-exposed (N = 38) were
studied at age 6 years (M = 6.3;SD = 0.5) using the Hearts & Flowers task (H&F) to
assess EFs. Maternal mood was measured during pregnancy (3rd trimester) and when
the child was age 6 years (Hamilton Depression Scale). Parent reports of child behavior
were also obtained (MacArthur Health & Behavior Questionnaire). Parents of prenatally
SRI-exposed children reported fewer child externalizing and inattentive (ADHD) behaviors.
Generalized estimate equation modeling showed a significant 3-way interaction between
prenatal SRI exposure, SLC6A4 variant, and maternal mood at the 6-year time-point on
H&F accuracy. For prenatally SRI-exposed children, regardless of maternal mood, the H&F
accuracy of children with reduced 5HTT expression (a short [S] allele) remained stable.
Even with increasing maternal depressive symptoms (though all below clinical threshold),
EFs of children with at least one short allele were comparable to children with the same
genotype whose mothers reported few if any depressive symptoms—in this sense they
showed resilience. Children with two long (L) alleles were more sensitive to context.
When their mothers had few depressive symptoms, LL children showed extremely
good EF performance—better than any other group. When their mothers reported more
depressive symptoms, LL children’s EF performance was worse than that of any other
group. In the face of a mother with a more depressed mood, EFs were best preserved
in children prenatally exposed to SRIs and with at least one short SLC6A4 allele. Yet,
prenatally-exposed LL children hold out promise of possibly superior EF if their mother’s
mood remains euthymic or improves.
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INTRODUCTION
Serotonin (5-HT) and its multiple receptors are highly expressed
in prefrontal cortex (PFC) and play key roles in influencing com-
plex cognition and resilience to stress (Canli et al., 2005; Lesch,
2007; Reuter et al., 2007; Homberg and Lesch, 2011). Dense pro-
jections of 5-HT neurons into prefrontal regions (Preece et al.,
2004), and a wide distribution of 5-HT receptors and 5-HT trans-
porter sites in PFC (Varnäs et al., 2004) contribute to 5-HT’s
role in cognition (King et al., 2008). Critical cognitive capaci-
ties that rely on PFC and related structures (Miller and Cohen,
2001; Braver et al., 2002; Petrides, 2005; Champod and Petrides,
2007; Zanto et al., 2011) are termed executive functions (EFs),
and include abilities to (1) focus, sustain and shift attention
(executive attention), (2) resist the pulls and temptations of
external stimuli, our emotions, or engrained behavioral tenden-
cies, inhibit acting impulsively, taking a moment to make a more
considered response (inhibitory control), (3) hold information
in mind and work with it, such as updating one’s thinking or
planning when given new information, considering alternatives,
or mentally relating pieces of information to one other (work-
ing memory), and (4) creative problem-solving, flexibly adjusting
to changed demands, priorities, new obstacles or opportunities
(cognitive flexibility; Miyake et al., 2000; Diamond, 2013). Not
surprisingly, good EFs are critical for all aspects of life, includ-
ing mental and physical health and success in school and in life
(Moffitt et al., 2011; Diamond, 2013). For example, childhood
EFs predict school readiness and success in math and reading
throughout all school years from kindergarten through university
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better than does IQ, even when controlling for SES (Bull and
Scerif, 2001; Blair, 2002; Riggs et al., 2004; Blair et al., 2005;
Gathercole et al., 2005; Blair and Razza, 2007).
5-HT plays a critical role in brain development (Kalueff et al.,
2010; Olivier et al., 2011). In animal models, developmental shifts
in central 5-HT signaling shape early cognitive capacities setting
pathways for learning and behavior later in life (see for review
Kalueff et al., 2010). Little, however, is known about how devel-
opmental changes in 5-HT influence early cognitive development
in humans during childhood.
The increasing use of serotonin reuptake inhibitor (SRI)
antidepressants to manage maternal mood disorders during preg-
nancy (Cooper et al., 2007) raises critical questions about the
impact of prenatal altered central 5-HT levels on the develop-
ment of systems that regulate attention, working memory, and
self-control (i.e., EFs) in childhood (Kalueff et al., 2010; Hanley
and Oberlander, 2012). SRIs primarily act by blocking reuptake
of serotonin transporter protein (5-HTT), thereby increasing how
much, and how long, extracellular 5-HT remains active and avail-
able. SRIs readily cross the placenta and the blood-brain barrier
(Kim et al., 2006) altering fetal central 5-HT levels (Laine et al.,
2003). Prenatal SRI exposure affects (1) fetal (Salisbury et al.,
2009; Mulder et al., 2011) and newborn neurobehavior (Moses-
Kolko et al., 2005), (2) neonatal stress regulation (Oberlander
et al., 2002, 2005), (3) shifts language perception during the first
year of life (Weikum et al., 2012), and (4) is associated with
emotional regulation in toddlers (Oberlander et al., 2010).
Why some, but not all, children are affected by prenatal SRI
exposure is still a central and pressing question (Hanley and
Oberlander, 2012). In the early school years prenatally exposed
children appear to have typical language development, behav-
ior and IQ (Nulman et al., 2002). However, not all outcomes
can be specifically attributed to prenatal antidepressant exposure.
Distinguishing the concurrent impact of pre and postnatal mater-
nal mood disturbances remains challenging (Oberlander et al.,
2010).
The pre-synaptic membrane-bound serotonin transporter
protein (5-HTT)—the very target of SRI antidepressants—is cen-
tral to the regulation of intra-synaptic 5-HT. Allelic variations
in 5-HTTLPR (SLC6A4) influences gene transcription and the
amount of 5-HT available at postsynaptic sites (Lesch et al.,
1996). The short (S) variant is associated with reduced gene tran-
scription and reduced levels of 5-HTT protein, with an ∼50%
reduction in 5-HT reuptake compared to the long (L) variant
(Heils et al., 1996; Homberg et al., 2007a). Reduced 5-HTT pro-
tein availability and 5-HT reuptake results in a higher effective
“serotonin dose.”
Homozygosity for the short (S) allele is associated with
increased stress sensitivity and risk for emotional disturbances
including anxiety and depression but better EFs (not unlike what
has been found for the COMT- MET genotype (Goldman et al.,
2005; Diamond, 2011). In combination with early life stressors,
the short allele has been widely studied as an important risk fac-
tor for mental illness later in life (Caspi et al., 2003; Kendler
et al., 2005; Lesch, 2007). For example, adolescents who encoun-
tered adversity in childhood and are homozygous for the short
allele of 5-HTTLPR have a heightened sensitivity to potential
negativity and threat in the environment and are more prone to
anxiety and depression (Owens et al., 2012). In animal models,
increased 5-HT levels secondary to 5-HTT blockade at develop-
mentally sensitive time periods (akin to a human 3rd trimester)
causes permanent axonal connection deficits in the somatosen-
sory cortex (Homberg et al., 2010), the lateral geniculate nucleus
(Gaspar et al., 2003), and altered neuronal dendritic branching,
elongation and pruning (Homberg et al., 2010; Liao and Lee,
2011; Olivier et al., 2011; Simpson et al., 2011; Zheng et al.,
2011). Beyond the newborn period, SRI-exposed animals demon-
strate decreased 5-HT levels—possibly via prolonged activation
of inhibitory receptors (i.e., 5-HT1a; Hensler, 2006). This might
underlie the reduced novelty investigation, poorer motor perfor-
mance (Lee and Lee, 2012), increased anxiety in conflict tasks and
anhedonia (Ansorge et al., 2004, 2008; Popa et al., 2008) reported
in fluoxetine-exposed mice. Adults with two short 5-HTTLPR
alleles consistently outperform those with one or two long alleles
on measures of EFs such as the Wisconsin Card Sorting test (Borg
et al., 2009) and go/no-go tests (Roiser et al., 2007), they also
show brain patterns consistent with better EFs (Enge et al., 2011).
Conversely, the L-allele of the 5-HTTLPR gene is associated with
poor EFs including impulsivity, inattention, and working mem-
ory deficits (see the meta-analysis by Gizer et al., 2009). Together
these findings support the notion that changes in transcriptional
activity associated with allelic variations in the 5-HTTLPR gene
and presumably reflecting alterations in central serotonin levels,
influence EFs in the mature adult brain.
Beyond genetic variations, experimental manipulations of cen-
tral serotonin levels in adults also appears to affect cognitive func-
tions. Acute SRI administration to healthy adults has been shown
to improve verbal fluency, a measure of EFs requiring memory of
words, inhibitory control to avoid repeating words, and cognitive
flexibility to switch to different paths and strategies for coming up
with words (Schmitt et al., 2001). Although reduced 5-HT, using
an acute tryptophan depletion (ATD) model with healthy volun-
teers, has been found to improve focused attention (Schmitt et al.,
2000; Evers et al., 2006), enhanced EF performance and reduced
impulsivity have also been found in some animal models of SRI
exposure (e.g., Sasaki-Adams and Kelley, 2001) but not all (e.g.,
Valluzzi and Chan, 2007). Importantly, 5-HTTLPR genotype and
SRI exposure do not affect, or inconsistently affect, non-EF cog-
nitive abilities such as recall and recognition memory and mental
rotation (e.g., 5-HTTLPR genotype: Roiser et al., 2006; Mannie
et al., 2009, SRI exposure: Harmer et al., 2002; Siepmann et al.,
2003; Riedel et al., 2005).
An acute pharmacological exposure to an SRI or dietary deple-
tion of tryptophan in a mature brain may not result in the same
consequences as chronic prenatal SRI exposure and the associ-
ated long-term changes in prenatal 5-HT signaling that occurs
with such exposure across developmentally sensitive periods of
brain growth (Ansorge et al., 2004). To date, studies focusing
on the effects of prenatal SRI exposure have typically sought
to examine the consequences of what is generally considered
increased developmental serotonergic tone. However, in humans
the developmental course or behavioral consequences that might
follow prenatal SRI exposure (i.e., downstream lower serotonergic
tone) is not known. Given the developmental role of 5-HT, it is
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conceivable that prenatal changes in 5-HT either via genetic vari-
ations or prenatal SRI exposure might influence early cognitive
development in humans.
To further understand the developmental impact of prena-
tal SRI exposure on early cognitive development, we studied
whether prenatal exposure to SRI antidepressants or maternal
mood affects core cognitive skills (EFs) in early childhood, con-
trolling for prenatal maternal mood. Secondarily, we also sought
to examine whether changes in EFs are moderated by the child’s
SLC6A4 genotype, reflecting genetic variations in the capacity
to control serotonergic tone that may influence the impact of
exposure to maternal mood or SRIs. Given fetal changes in
5-HT signaling secondary to prenatal SRI exposure, and the lit-
erature showing improved cognitive function among S carriers,
we expected that antidepressant exposure and reduced SLC6A4
transcription (at least one short [S] allele) at a developmentally
sensitive time (i.e., in utero) would be associated with improved
EF capacity in early childhood, while elevatedmaternal depressive
symptoms would have an opposing effect at 6 years of age.
MATERIALS AND METHODS
PARTICIPANTS
Children in this study are part of a longitudinal cohort study
examining the effects of prenatal exposure to SRIs and maternal
mood disturbances in 98 mothers recruited during their sec-
ond trimester of pregnancy. Approval was obtained from the
University of British Columbia Ethics Board and the Children’s
andWomen’s Health Centre of British Columbia Research Review
Committee. Written informed parental consent was obtained
to follow the development of these children. All mothers,
regardless of their mood or medication status, were physician-
referred or self-referred from the Reproductive Mental Health
Clinic at British Columbia Women’s Hospital and Health Centre
(a tertiary-care service), community midwife clinics or family
physician practices in the greater Vancouver metropolitan area.
All SRI-treated mothers had started taking medications based
on clinical need, had a diagnosis of a mood disorder, and were
already taking antidepressant medications at the time of con-
ception. Women in the non-SRI group had a range of mood
symptoms at the time of recruitment as assessed by the Hamilton
Rating Scale for Depression (HAM-D; see Table 1). Of the origi-
nal 98 mothers, 4 withdrew before the baby was born and another
4 withdrew before the end of the child’s first year. At 6 years, an
additional 26 children were unavailable for study (22 families had
moved and 4 mothers had withdrawn by 3 years). At the time
of this study, 64 children (26 prenatally SRI-exposed and 38 non-
exposed) were seen at mean age 6.3 years (SD = 0.51 years). From
this sample, 25 exposed and 32 non-exposed had both prenatal
maternal mood scores and samples of the child’s blood available
for genotyping.
CHILD MENTAL HEALTH SYMPTOMATOLOGY
Measures of child mood and behavior were obtained from
the mental health symptomatology section of the MacArthur
Health and Behavior Questionnaire (HBQ; Boyce et al., 2002;
Essex et al., 2002) that was completed by maternal report
(HBQ-P) and yieldedmeasures of internalizing, externalizing and
Table 1 | Maternal characteristics.
Non-exposed
(n = 38)
SRI-exposed
(n = 26)
T p-value
Prenatal HamA (mean)
(SD) (n = 35
non-exposed and 25
SRI-exposed)
5.5 (4.75) 9.58 (6.75) −2.8 0.007
Prenatal HamD (mean)
(SD) (n = 34
non-exposed and 25
SRI-exposed)
3.64 (4.26) 8.54 (6.28) −3.66 0.001
Maternal smoking during
pregnancy
0 0 0
Maternal alcohol
consumption (drinks in
pregnancy) (n = 37
non-exposed)
2.49 (4.49) 3.69 (8.35) −0.74 0.462
Maternal age at birth
(years)
33.21 (4.93) 31.42 (4.6) 1.45 0.151
Maternal education
(years)
17.8 (2.71) 15.27 (2.39) 3.83 0.001
MATERNAL SLC6A4 GENOTYPE (n’s)
LL 10 7 0.704
1S 27 18
Attention-Deficit and Hyperactivity Disorder (ADHD) behav-
iors for each child. The HBQ was derived from the Ontario
Child Health Study measure designed to map onto DSM-III-R
symptom criteria (Boyle et al., 1993). The HBQ-P has strong
psychometric properties and has been used to assess child men-
tal health across multiple ages from 4.5 years into adolescence
(Ablow et al., 1999; Essex et al., 2006; Shirtcliff and Essex, 2008)
The mental health scales have been shown to discriminate groups
of children with and without signs of early psychopathology
(Luby et al., 2002).
The HBQ-P, administered in questionnaire format, assesses
symptoms ranging from “never or not true” to “often or very
true.” Symptoms in three domains were analyzed: (1) ADHD
symptoms consist of items indexing inattention, impulsivity,
and hyperactivity. (2) Externalizing symptoms consist of items
indexing oppositional defiant behaviors and conduct problems.
(3) Internalizing symptoms consist of items indexing symptoms
of depression, separation anxiety, and generalized anxiety. In
addition to mean symptom level, the percentage of children
above clinical cutoffs was examined. Clinical cutoffs for par-
ent reported ADHD, externalizing, and internalizing symptoms
(1.2, 0.68, 0.71, respectively) were set based on previous analy-
sis of the HBQ-P (Lemery-Chalfant et al., 2007) with children of
approximately the same age as in the present study.
EF TASKS
EFs were assessed using the H&F task, a computerized mea-
sure that has been validated with children 4–13 years of age and
with adults (Davidson et al., 2006; Diamond et al., 2007). This
task assesses inhibition, working memory and cognitive flexibil-
ity. A stimulus appears to the right or left of a computer screen
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on every trial. On Block 1 of the task (the congruent block),
participants have only to do what comes naturally (i.e., press-
ing on the same side as the stimulus); no EFs are taxed. On
Block 2 (the incongruent block), participants had to resist that
prepotent response and instead press on the side opposite the
stimulus. On Block 3 (the mixed block), the two types of trials
are randomly intermixed, requiring remembering both rules and
mentally translating “same [or opposite] side” into “right [or left]
hand,” and flexibly switching between the two rules, inhibiting
one to apply the other.
The children came to the study center mid-morning and first
performed a warm up task (about 5min). During the task, chil-
dren were told to respond to a stimulus as fast as they were able
and this gave them practice with the computerized set-up. The
children then performed the H&F task (about 10min). Practice
trials were given before both the congruent and incongruent
blocks (see Davidson et al., 2006; Diamond et al., 2007). In both
blocks, children were given up to 6 s to respond, and 10 s in the
mixed block. Responses > 2000ms were considered incorrect
(inattentive) and those< 250ms, impulsive. Both responses were
excluded. Five trials out of 1860 trials were > 2000ms (0.26%),
and there were no trials < 250ms (out of 1860 trials in total).
Outlier trials were removed by using a lower and upper thresh-
old of 2 standard deviations from the mean RT per trial type per
block and per subject.
Two dependent measures were tabulated for each block (i.e.,
Congruent, Incongruent, etc): (1) correct responses or accuracy
(% correct = #correct/[# trials]) and (2) Reaction time or speed
of response (reaction time, RT > 250msec for correct trials only).
Reaction time was a Choice RT tabulated every time a stimulus
appeared during the three-block task and the stimulus appeared
at random intervals (one button used) (Kail and Salthouse, 1994).
MATERNAL MOOD
Maternal mood was assessed during the third trimester of preg-
nancy (mean 33.8 week; SD 1.25 weeks), and again at the
6-year timepoint using the HAM-D; (Hamilton, 1960), a 21-
item clinician-rated measure of depressive symptoms with a score
ranging from 0 to 63.
SLC6A4 GENOTYPING
Genomic DNA was extracted from neonatal whole blood sam-
ples using the Flexigene DNA Blood Kit (Qiagen, Valencia,
California). The S and L alleles of SLC6A4 were identified as
previously described in (Lesch et al., 1993). Polymerase chain
reaction was performed with oligonucleotide primers flank-
ing the polymorphism (corresponding to nucleotide positions
-1416 to -1397 [stpr5, 5_- GGCGTTGCCGCTCTGAATGC] and
-910 to -888 [stpr3, 5_-GAGGGACTGAGCTGGACAACCAC])
of the 5_-flanking regulatory region of SLC6A4 to generate a
484-bp (S short allele) or a 528-bp (L long allele) polymerase
chain reaction product. Polymerase chain reaction amplifica-
tion was performed in a final volume of 30μL with 50 ng of
genomic DNA, 2.5mM deoxyribonucleotides (dGTP/7-deaza-2_-
dGTP = l/l), 0.1μg of sense and antisense primers, 10mM
Tris hydrochloride (pH 8.3), 50mM potassium chloride, 1.5mM
magnesium chloride, and 1 U of Taq DNA polymerase. For
quality control, 5% of the samples were randomly chosen to
be retested and their genotypes were consistent with previous
results.
STATISTICAL ANALYSES
Two separate analytic approaches were used to study behavioral
outcomes. To analyze child behavioral differences using mater-
nal report, a multivariate analysis of covariance (MANCOVA)
was used to examine group (SRI exposed vs. non exposed) dif-
ferences in child behavior, with child age (at the time of the
6 year study, prenatal (3rd trimester) and postnatal (6 year)
maternal mood as covariates. Maternal mood was used as a
continuous measure to allow us to account for the wide range
of depressive symptoms observed among both SRI-exposed and
non-exposed groups. Across time, somemothers in our untreated
group became depressed and some crossed over to the SRI treated
group. Maternal mood measures at both time points (prenatally
and at the 6 year study) helped to account for these changes.
General Estimating Equation (GEE) modeling was used to
examine group (SRI exposed vs. non-exposed) and genotype (LL
vs. at least one S allele) in relation to each of the three com-
puterized H&F conditions. Due to a limited number of children
with SRI exposure and two short alleles (n = 7), children with
at least one short allele (LS and SS) were grouped together to
yield the ≥1 S allele group. With the GEE approach we were able
to examine main effects (SRI exposure and genotype) and inter-
actions simultaneously. The role of genotype was examined as
a possible moderator of the effects of prenatal exposure on EFs
by comparing performance for each EF task block and interac-
tions between exposure group and SLC6A4 genotype (LL vs. at
least one S allele [SS or LS]), accounting for pre- and post-natal
maternal mood. GEE extends the generalized linear modeling to
allow for analysis of repeated measurement of accuracy (a bino-
mial dependent variable). GEE analyses were performed using
SPSS Statistics 18. All p-values less than 0.05 were considered
significant.
RESULTS
Demographic and behavioral outcomes for the mothers and their
children are presented in Tables 1, 2. With the exception of mater-
nal education, maternal mood prenatally and at the 6 year study,
child age at the time of the study (p = 0.03), and the chil-
dren’s 5-min APGAR scores (p = 0.026), no significant group
differences (SRI exposed vs. non-exposed) were observed. As SRI-
exposed children were older than the non-exposed children at the
time of the study, child age was included as a covariate in the
analyses. While the 5-min APGAR scores were statistically differ-
ent between groups, the clinical impact of these differences (i.e.,
between scores of 9.13 vs. 8.73, Table 1) would not reflect a signif-
icant difference in outcome and thus were not included in further
analyses. We did not include maternal education as a covariate as
all mothers had high levels of education.
CHILD MENTAL HEALTH
In SRI-exposed children, significantly fewer ADHD (p = 0.03)
and disruptive externalizing symptoms (p = 0.019) were
reported by parents, after adjusting for child age, 3rd-trimester
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maternal mood and maternal mood at the time of the study.
No differences in internalizing behaviors were found between
exposure groups (Table 2). Maternal depression symptoms were
associated with increased report of externalizing (r = 0.314;
p = 0.01) and ADHD behaviors (r = 0.251; p = 0.039). In
separate GEE models, internalizing and externalizing behaviors,
respectively, were not predictive of EF performance, regardless of
concurrent mother’s mood.
EF TASK (HEARTS AND FLOWERS)
To examine the effect of SRI exposure, SLC6A4 variant andmater-
nal mood on EF performance (accuracy and reaction time), a GEE
model was run separately on each of the three blocks of the EF
task. SRI exposure (yes/no) and SLC6A4 variant (LL vs. at least
Table 2 | Child characteristics.
Child characteristics Non-exposed
(n = 38)
SRI-exposed
(n = 26)
T p-value
Gestation age at birth
(mean weeks) (SD)
40.0 (1.35) 39.4 (1.63) 1.54 0.128
Birth weight (grams) (SD) 3531 (470) 3317 (480) 1.77 0.081
Birth length (cm) (SD) 51.7 (2.8) 50.71 (2.54) 1.48 0.143
Head circumference (cm)
(SD)
35.0 (1.36) 34.42 (1.27) 1.69 0.095
Apgars score (1min) 8.03 (1.6) 7.65 (1.55) 0.93 0.358
Apgars score (5min) 9.13 (0.53) 8.73 (0.87) 2.28 0.026
Sex (m:f) 18:20 10:16 −0.7 0.488
SLC6A4 genotype (n’s) 0.946
LL 11 9
1S 23 16
Age at study (yr) (SD) 6.22 (0.55) 6.51 (0.45) −2.28 0.03
Child mental health
symptomatology
F p-value
Internalizing symptomsˆ
Composite of
depression, separation
anxiety, and generalized
anxiety scores
0.33 (0.25) 0.33 (0.22) 0.253 0.617
% above clinical
threshold
6.3 8
Externalizing symptomsˆ
Composite of
oppositional defiant
behaviors and conduct
problem scores
0.29 (0.22) 0.23 (0.17) 5.831 0.019
% above clinical
threshold
6.3 0
ADHD Symptomsˆ
Composite of inattention,
impulsivity, and
hyperactivity scores
0.67 (0.39) 0.47(0.37) 4.954 0.03
% above clinical
threshold
9.4 0
ˆControlling for maternal mood (prenatal and 6 year) and child age.
one S) were factors. Trials was a repeated within-subject vari-
able, and maternal mood measures (prenatal and at the 6 year
study) and child age at test day were covariates. The outcome was
either accuracy (% correct response) or RT (in milliseconds) on
the EF task.
REACTION TIME
Overall, no SRI exposure group differences in RT (Figure 1) were
found in any of the 3 blocks. RT increased with increasing task
difficulty, but that did not differ by SRI exposure or genotype (LL
vs. ≥1 S allele). In a separate analysis of Choice RT task, older
children were faster (B = −35.5, p = 0.048). To control for speed
of responding faster, Choice RT was added to an overall GEE RT
model as a covariate. There was still no significant effect for SRI
exposure or SLC6A4 genotype (LL vs. ≥1 S allele) in the GEE RT
model.
ACCURACY
Overall, no SRI exposure group differences in accuracy (Figure 2)
were found on block 1 or 2. Differences emerged in the most
difficult third block where exposed children showed higher accu-
racy (suggesting better cognitive flexibility). However, the results
were not significant when controlling for child age. Not surpris-
ingly, older children performed better on the EF test (p = 0.004);
the results of the models were adjusted for child age. Maternal
depressed mood at 3rd trimester contributed, but not statistically
significantly (p = 0.064, OR = 0.943).
With each block, differences in accuracy between allelic varia-
tions and exposure groups began to emerge, but only in block 3,
with accuracy as the dependent variable, a significant main effect
for SLC6A4 genotype, child age and maternal mood emerged, as
well as a significant 3-way interaction between prenatal SRI expo-
sure, SLC6A4 variant, and maternal mood at age 6 years in the
GEE model (Table 3), controlling for child age.
When the mother’s current depressed mood symptoms were
relatively low (measured on test-day), EF performance did not
differ with the presence of prenatal SRI exposure (Figure 2) or
by child genotype (Figure 3A, using maternal mood grouped
by quartiles to illustrate the GEE results). However, the more
depressed the mother was currently, the more performance
FIGURE 1 | Reaction Time (ms ± sem) by block and SRI Exposure.
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between the groups began to diverge. In the face of higher
depressive maternal symptoms (4th quartile), EF performance of
children with no prenatal SRI exposure was poor. Accuracy was
significantly and inversely related to how depressed their mother
was currently (B = 0.099; 95% CI [0.035–0.163]; χ2 = 9.295;
p = 0.002) and this was particularly true for children with the LL
variant (B = −0.092; 95% CI [−0.171–−0.014]; χ2 = 5.29; p =
0.021). Namely, children prenatally exposed to SRIs and with at
least 1 S allele and high concurrent maternal depressive symptoms
showed no decrement in accuracy. However, among children with
LL variant of SLC6A4, accuracy was worse in children with symp-
tomatic mothers (3rd and 4th quartiles) compared with those
with less symptomatic mothers. In contrast, children with =1
S allele had relatively stable performance regardless of mothers’
depressive mood states (Figure 3B).
DISCUSSION
On a test of EFs (H&F; requiring inhibition, working memory,
and cognitive flexibility), the effect of prenatal SRI exposure was
markedly different in 6-year-old children depending on the child’s
FIGURE 2 | Accuracy (CR % ± SEM) by block and SRI exposure (CR%
corrected for age).
SLC6A4 genotype and mother’s concurrent mood. SRI exposed
children with an LL genotype showed pronounced differences
in their EFs depending on their mother’s current mood. SRI-
exposed children with at least one short SLC6A4 allele showed
resilience (no impairment in inhibition and attention). Even in
the face of more symptomatic mothers, the accuracy of the ≥1 S
children on the difficult mixed Block 3 of the H&F test did not
differ. In contrast, children with two L alleles, were far more sen-
sitive to the context of life with a depressed mother. When their
mother had few or no depression symptoms, LL children did
FIGURE 3 | (A) Accuracy (% Correct Response, Block 3 ± SEM), SRI
exposure & Maternal Depressed Mood at 6 years postpartum (quartile).
Trend lines reflect differences in CR% across maternal mood between
exposure groups. (B) Accuracy (CR%, Correct Response, Block 3 ± SEM),
SLC6A4 Allelic variations & Maternal Depressed Mood at 6 years
postpartum (quartile). Trend lines reflect differences in CR% across
maternal mood between allele groups.
Table 3 | GEE model results (reflecting slope) showing the effect of SRI exposure, SLC6A4 variant, and maternal mood on EF task accuracy.
Parameter B* 95% Wald confidence interval Wald χ2 p-value
Lower Upper
SRI exposure 0.516 −0.236 1.268 1.807 0.179
SLC6A4 LL 1.051 0.263 1.838 6.838 0.009
Third trimester mood (HAMD) −0.059 −0.122 0.003 3.429 0.064
Maternal Mood Study Day (HAMD) 0.099 0.035 0.163 9.295 0.002
Child age at study day 0.682 0.221 1.143 8.398 0.004
Prenatal mood * SRI non-exposed * SLC6A4 LL −0.047 −0.162 0.068 0.632 0.427
Prenatal mood * SRI non-exposed * SLC6A4 ≥ 1 s 0.056 −0.024 0.136 1.884 0.17
Prenatal Mood * SRI exposed * SLC6A4 LL −0.02 −0.094 0.055 0.271 0.602
Six year maternal mood * SRI non-exposed * SLC6A4 LL −0.171 −0.261 −0.082 14.098 <0.001
Six year maternal mood * SRI non-exposed * SLC6A4 ≥ 1 s −0.139 −0.216 −0.061 12.237 <0.001
Six year maternal mood * SRI exposed * SLC6A4 LL −0.092 −0.171 −0.014 5.29 0.021
B* is the non-standardized regression coefficient. Bold value indicates p < 0.001.
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extremely well—no other group regardless of SLC6A4 genotype
or mother’s mood had mean scores that were as high. However,
when their mothers were highly symptomatic, they performed
worse than any other group including ≥1 S children with equally
symptomatic mothers and LL children with less symptomatic
mothers.
Differences in accuracy were most evident on the most-
demanding EF Block. In general EF differences between groups
often emerge only when cognitive skills are pushed to their
limit. Children’s EFs were not significantly affected by the child’s
mood (anxiety or depressive symptoms), though in this cohort
there was little variation in the children’s subclinical mood
symptoms. Parents reported fewer inattentive and externaliz-
ing behaviors in children with prenatal SRI exposure regard-
less of the child’s genotype. That might be because the SRI
improved the child’s postnatal environment (by improving the
mother’s mood) or because the effect on the 5HT signaling
in the child secondary to prenatal SRI exposure. The bene-
fit of one S allele of SLC6A4 to EFs (cognitive control, self-
regulation, inhibitory control) in children prenatally exposed
to an SRI antidepressant became most apparent when chil-
dren were in a particular environment (i.e., when their moth-
ers were relatively more depressed). In that environment, the
effects of the LL exposed children suffered but the effects of
the exposed with ≥1 S allele did not. In this way maternal
depression might act as a “prism,” dramatically increasing vari-
ability in EFs, according to prenatal SRI exposure and allelic
variation.
Critical to identifying the impact of prenatal SRI exposure, is
distinguishing the effects of the antidepressant from the maternal
mood disturbance (pre and postnatal) that resulted in antidepres-
sant medication use. Sensitivity to maternal depressed mood and
its impact on cognitive development has been widely reported
across childhood (Gelfand and Teti, 1990; Goodman and Gotlib,
1999; Elgar et al., 2004; Gross et al., 2008). Long before birth,
early life influences are already shaping core cognitive capacities
that go on to become critical for learning and mental health dur-
ing childhood (Kolb et al., 2003; Fox et al., 2010). Preterm birth
(Davis et al., 2011), prenatal psychological distress (Buss et al.,
2011) and maternal behavioral risks (smoking, alcohol use, drug
use) (Espy et al., 1999; Schonfeld et al., 2006; Blood-Siegfried and
Rende, 2010) exert an influence on early EFs. Early and chronic
exposure to maternal symptoms adversely affects early develop-
ment of EFs (Hughes et al., 2013). Yet, not all outcomes on
cognitive developmental pathways are necessarily negative in this
setting (DiPietro et al., 2006), raising critical questions of how
maternal mood affects cognitive development and who remains
at risk, even in the presence of maternal pharmacotherapy. In
the present study, prenatal SRI exposed children with at least one
S allele showed stable EF functioning regardless of whether their
mother was more or less depressed. Moreover, maternal mood
in the present study, when their children were 6 years old, was
mainly at a subthreshold level, well-below a typical DSM-IV cri-
teria for Major Depressive Diorder (MDD; American Psychiatric
Association, 2000), thus highlighting the importance of a spec-
trum of maternal mood symptoms on child development, rather
than a clinical cutoff score.
Converging evidence also points to links between changes in
5-HT signaling and cognition in both animal models and humans
(Munafò et al., 2009; Homberg et al., 2010), though not all stud-
ies have been consistent (Schmitt et al., 2006; Homberg and Lesch,
2011). Increased 5-HT signaling, secondary to SRI treatment and
genetic variations, has been associated with improved cognitive
functions. 5-HT transporter knockout rodent models, analogous
to an extremely low activity (short allele) variant, have been asso-
ciated with improved cognitive flexibility during reversal learning
tasks (Brigman et al., 2010; Nonkes et al., 2012), as well as mor-
phological frontal cortex changes reflecting an increase in central
5-HT levels (Jedema et al., 2009; Kalueff et al., 2010; Nonkes
et al., 2010). Consistent with these findings, early developmental
exposure to fluoxetine has been associated with improved spatial
learning in rats (Bairy et al., 2006). In humans, carriers of the S
allele showed improved performance on an attentional inhibition
task (Roiser et al., 2007). Adults homozygous for SS alleles outper-
form LL carriers on cognitive tasks requiring inhibitory control,
including episodic memory and attention (Roiser, 2011), reaction
time (Enge et al., 2011) and executive attention (Strobel et al.,
2007). Among S carriers, better performance on the Wisconsin
Card Sorting test has been reported (Borg et al., 2009), reflecting
the impact of increased 5-HT signaling on cognitive flexibility. In
contrast, lower 5-HT levels also appear to impair reversal learning
(Clarke et al., 2007). Cognitive consequences of increased 5-HT
signaling associated with SRI antidepressant exposure have shown
mixed results as well. In animal models, not all findings reflect the
same impact on cognitive flexibility (Homberg et al., 2007b).
The neuroanatomical, and functional consequences of chang-
ing 5-HT levels depend on the timing (critical periods) and
direction (increased or decreased) of the developmental expo-
sure to changes in 5-HT signaling and may differ from the
impact of an acute exposure in a mature organism. (Ansorge
et al., 2007; Kalueff et al., 2010). In a rodent model, SRI expo-
sure during a very specific postnatal period (postnatal days 4–21)
of development is also associated, paradoxically, with reduced
exploratory behavior, and depressive and anxiety-related behav-
iors in adulthood. These effects mimic the very effects of genetic
5-HTT inactivation (i.e., gene knockout models leading to the
absence of the transporter); suggesting that increased seroton-
ergic signaling during a developmentally critical period predis-
poses to subsequent affective disturbances (Lira et al., 2003;
Ansorge et al., 2004, 2008). This central serotonergic auto-
feedback hypothesis suggests that increased feedback signaling
in the presence of high serotonergic tone blunts maturation
of the 5-HT system via long-term developmental activation of
inhibitory receptors (i.e., 5-HT1a), paradoxically leading to psy-
chopathology later in life (Hensler, 2006; Ansorge et al., 2007;
Simpson et al., 2011).While onemight consider thatmaternal SRI
treatment during pregnancy could potentially confer benefit on
fetal neurodevelopment—via improved maternal mood—such
exposure could also have detrimental effects later in childhood,
reflecting a long-term consequence of decreased serotonergic
tone. SRIs may elevate fetal 5-HT levels, but then ultimately
lead to decreased 5-HT signaling later in life and restricted sero-
tonergic system development. The serotonergic auto-feedback
hypothesis, however, is not a unitary construct and further work
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is needed to understand how developmental changes in 5-HT sig-
naling influences the downstream interaction with the social envi-
ronment inherent to life with a depressed mother that together
contributes to childhood behavior in this setting (Oberlander
et al., 2009).
Importantly, not all factors that affect 5-HT signaling confer
the same risk. Early life experiential variables influence suscep-
tibility to environmental factors (Moffitt et al., 2005; Caspi and
Moffitt, 2006) and not all outcomes associated with the short
allele are necessarily negative (Risch et al., 2009). While adults
with two short alleles may be at increased risk for depression
(Caspi et al., 2003) following early life adversity, those raised in
a nurturing environment may ultimately have a lower risk for
depressive symptoms (Taylor et al., 2006). Increased central 5-HT
associated with the SLC6A4 short allele may therefore contribute
to an increased sensitivity to environmental stimuli or hyper vig-
ilance, leading to adaptation in one setting or an increased risk
for poor mental health in another. In other words, in a low
reward or low adversity setting, such hyper vigilance may con-
fer an actual benefit that increases processing of relevant stimuli
improving learning and social cognition (Homberg and Lesch,
2011). In the current study, serotonergic tone, via either prena-
tal SRI exposure or SLC6A4 allelic variations, appeared to affect
a self-regulatory capacity that might heighten sensitivity to a
world with a depressed mother. Highly vigilant individuals may
therefore either become vulnerable or resilient, depending on the
demands of that social environment.
Our findings may also illustrate the influence of how allelic
variations in the context of both early (i.e., fetal) and ongo-
ing (i.e., postnatal/childhood) life experience shape a “biological
sensitivity to context” (Boyce et al., 1995; Ellis et al., 2011)
influencing adaptation and the diversity of child developmental
outcomes following early changes in 5-HT signaling. This model
proposes that phenotypic plasticity might enable a child to match
their biological and behavioral capacities to the demands of their
developmental environment. In this context, genetic variations
may confer advantages for some children in supportive environ-
ments, but disadvantages for others who face social adversity in
the context of maternal depression (Boyce and Ellis, 2005). Our
findings showing higher accuracy in the non-exposed, LL chil-
dren in the context of a minimally depressed mother, supports
this claim.
Our findings point to a broader understanding of the impact
of serotonin developmental neurobiology. While the “S” allele has
been widely considered the “risk” or “sensitive” allele whereby the
effect varies with context (Barr et al., 2004; Belsky and Pluess,
2009; Homberg and Lesch, 2011; van Ijzendoorn et al., 2012) our
findings suggest that under certain circumstances carriers of the
L allele may also be equally or even more sensitive to context.
How this reflects the underlying changes in serotonin signaling
(i.e., increased or decreased serotonin at developmentally sensi-
tive times) remains a matter of speculation (Oberlander et al.,
2009). Under some circumstances the L allele may confer vulner-
ability such as fear in adults exposed to carbon dioxide (Schruers
et al., 2011) or aggression in 3-year old children of prenatally anx-
ious mothers (Oberlander et al., 2010) when compared with LS
or S allele carriers. Our findings take this observation one step
further. Even with similar prenatal exposures, two children with
different genetic inheritance show divergent developmental out-
comes depending on the environmental circumstances they find
themselves in at 6 years of age. Namely, while the impact of allelic
variations may be environmentally dependent and the influence
can, depending on the childhood context they grow into, go in
both directions, thereby reflecting both developmental risk in
some settings and resiliency in others. In this way, gene by envi-
ronment outcomes may reflect a “conditional adaptation” (Boyce
and Ellis, 2005) whereby allelic variations can be susceptible to
both stressful and supportive contexts—for better and for worse
(Belsky et al., 2007).
Conceivably there could be both advantages and disadvan-
tages to improved EF performance. On one hand heightened
vigilance may reflect an increased sensitivity in the social world
of early childhood. However, it may also reflect a relative deficit
in self-regulatory capacity which might illustrate a “leading edge”
or susceptibility for a mood disorder that may emerge later
in childhood (Taghavi et al., 1999). Interestingly, in a rodent
model, an early increase in 5-HT signaling was associated with
early fluoxetine exposure and paradoxically leads to increased
anxiety and depression behaviors in adulthood (Ansorge et al.,
2004). Earlier we reported that increased anxiety and depres-
sive symptoms were observed by parents in 3 year olds with
prenatal SRI exposure, though current increasedmaternal depres-
sion symptoms also contributed to child behavior (Oberlander
et al., 2010). Now by 6 years of age, in the same cohort, lev-
els of anxious behaviors did not differ between non-exposed
children and fewer externalizing and attentional behaviors were
observed in the exposed children. The long term implications
of this unfolding longitudinal pattern remains unknown, how-
ever, improved EFs may reflect an endophenotype that includes
increased vigilance that may evolve into a clinically apparent
mood disorder in later childhood. Although increased vigilance
may confer benefits for short-term tasks in one context (e.g., dur-
ing a laboratory EF testing), it may be disadvantageous in the long
run under other typical childhood circumstances (e.g., during an
entire school day). While improved cognitive control in one set-
ting may confer a developmental advantage (such as life with a
depressed mother), the long term consequences of our findings in
other childhood contexts (e.g., stressful classroom) need further
study.
LIMITATIONS
A number of limitations need mentioning. First, without direct
measures of central changes in 5-HT signaling in utero and again
at 6 years, we can only infer that prenatal SRI exposure and
genetic variations did indeed alter 5-HT function accounting for
our findings. Further, serotonergic system function is dependent
on multiple neurochemicals, receptors and related genes, and a
focus on prenatal SRI exposure and genetic variations for 5-HT
transporters offer only a limited insight into a complex develop-
mental system underlying early human cognitive development.
Additionally, study of parent-child relationships which have been
noted as key influences on individual differences in a develop-
ing child’s executive capacities (Carlson, 2003; Hughes and Ensor,
2009; Bernier et al., 2011) are needed.
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SUMMARY
This study sought to examine the long-term effects of prenatal SRI
exposure on EFs at 6 years of age and to determine whether effects
are moderated by maternal mood and/or genetic variations. For
prenatally SRI-exposed children, regardless of maternal mood,
accuracy of children with reduced 5HTT expression (at least one
short [S] allele) remained stable regardless of maternal depressive
symptoms. In particular, even with somewhat depressed moth-
ers (though all symptoms were below clinical threshold), these
children’s EFs were comparable to children with the same geno-
type whose mothers showed few if any depressive symptoms—in
this sense, they showed resilience. In contrast, children with two
long (L) alleles appeared sensitive to context. When their moth-
ers reported relatively fewer depressed symptoms, LL children
showed extremely good EF performance—better than any other
group. When mothers reported more depressive symptoms, LL
children’s EF performance was worse than that of any other group.
Further, parents reported fewer inattentive behaviors in their SRI
exposed children.
In the face of a mother with a relatively more depressed mood
(albeit not at clinical levels), EFs were best preserved in children
prenatally exposed to SRIs and with at least one short SLC6A4
allele. Yet, prenatally-exposed LL children hold out promise of
possibly superior EF if their mother’s mood remains euthymic
or improves. Together these findings may reflect effects of both
increased and decreased early serotonergic signaling associated
with an increased sensitivity to social and relational contexts.
While improved EFs might reflect an apparent resiliency to an “at
risk” social environment, the long term and clinical implications
of these findings remain to be determined.
ACKNOWLEDGMENTS
We thank the mothers and their children who participated and
contributed to this work. We are grateful to Joannie Maynard
and Deborah Heard for their assistance with data collection. This
research was funded by March of Dimes Foundation (USA), the
Child and Family Research Institute (UBC) and the Canadian
Institutes of Health Research [Tim F. Oberlander (PI), CIHR
#MOP 57837] and 6 year grant (MOP-86296). Tim F. Oberlander
is the R. Howard Webster Professor in Brain Imaging and
Early Child Development (UBC). Whitney M. Weikum was sup-
ported by postdoctoral fellowships from CIHR, Michael Smith
Foundation for Health Research and funding from the Sunny Hill
Foundation. Funding sources had no role in the study.
REFERENCES
Ablow, J. C., Measelle, J. R., Kraemer,
H. C., Harrington, R., Luby, J.,
Smider, N., et al. (1999). The
macarthur three-city outcome
study: evaluating multi-informant
measures of young children’s symp-
tomatology. J. Am. Acad. Child
Adolesc. Psychiatry 38, 1580–1590.
doi: 10.1097/00004583-199912000-
00020
American Psychiatric Association.
(2000). Diagnostic and Statistical
Manual of Mental Disorders:
DSM-IV-TR®. Washington, DC:
American Psychiatric Pub.
Ansorge, M. S., Hen, R., and Gingrich,
J. A. (2007). Neurodevelopmental
origins of depressive disorders.Curr.
Opin. Pharmacol. 7, 8–17. doi:
10.1016/j.coph.2006.11.006
Ansorge, M. S., Morelli, E., and
Gingrich, J. A. (2008). Inhibition of
serotonin but not norepinephrine
transport during development
produces delayed, persistent
perturbations of emotional behav-
iors in mice. J. Neurosci. 28,
199–207. doi: 10.1523/
JNEUROSCI.3973-07.2008
Ansorge, M. S., Zhou,M., Lira, A., Hen,
R., and Gingrich, J. A. (2004). Early-
life blockade of the 5-HT trans-
porter alters emotional behavior in
adult mice. Science 306, 879–881.
doi: 10.1126/science.1101678
Bairy, K., Madhyastha, S., Ashok, K.,
Bairy, I., and Malini, S. (2006).
Developmental and behavioral
consequences of prenatal fluoxetine.
Pharmacology 79, 1–11. doi:
10.1159/000096645
Barr, C. S., Newman, T. K., and
Lindell, S., et al. (2004). Interaction
between serotonin transporter gene
variation and rearingcondition in
alcohol preference and consump-
tion in female primates. Arch. Gen.
Psychiatry 61, 1146–1152. doi:
10.1001/archpsyc.61.11.1146
Belsky, J., Bakermans-Kranenburg,
M. J., and van IJzendoorn, M.
H. F. (2007). For better and for
worse: differential susceptibility
to environmental influences. Curr.
Dir. Psychol. Sci. 16, 300–304. doi:
10.1111/j.1467-8721.2007.00525.x
Belsky, J., and Pluess, M. (2009).
Beyond diathesis stress: differen-
tial susceptibility to environmen-
tal influences. Psychol. Bull. 135,
885–908. doi: 10.1037/a0017376
Bernier, A., Carlson, S. M., Deschênes,
M., and Matte-Gagné, C. (2011).
Social factors in the development
of early executive functioning:
a closer look at the caregiv-
ing environment. Dev. Sci. 15,
12–24. doi: 10.1111/j.1467-7687.
2011.01093.x
Blair, C. (2002). School readiness:
Integrating cognition and emotion
in a neurobiological conceptualiza-
tion of children’s functioning at
school entry. Am. Psychol. 57, 111.
doi: 10.1037/0003-066X.57.2.111
Blair, C., Granger, D., and Peters
Razza, R. (2005). Cortisol reactiv-
ity is positively related to execu-
tive function in preschool children
attending Head Start. Child Dev.
76, 554–567. doi: 10.1111/j.1467-
8624.2005.00863.x
Blair, C., and Razza, R. P. (2007).
Relating effortful control, executive
function, and false belief under-
standing to emerging math and
literacy ability in kindergarten.
Child Dev. 78, 647–663. doi:
10.1111/j.1467-8624.2007.01019.x
Blood-Siegfried, J., and Rende, E. K.
(2010). The long-term effects of
prenatal nicotine exposure on neu-
rologic development. J. Midwifery
Womens Health 55, 143–152. doi:
10.1016/j.jmwh.2009.05.006
Borg, J., Henningsson, S., Saijo, T.,
Inoue, M., Bah, J., Westberg, L.,
et al. (2009). Serotonin trans-
porter genotype is associated
with cognitive performance
but not regional 5-HT1A
receptor binding in humans.
Int. J. Neuropsychopharmacol.
12, 783–792. doi: 10.1017/
S1461145708009759
Boyce, W. T., Chesney, M., Alkon,
A., Tschann, J. M., Adams, S.,
Chesterman, B., et al. (1995).
Psychobiologic reactivity to stress
and childhood respiratory illnesses:
results of two prospective studies.
Psychosom. Med. 57, 411–422.
Boyce, W. T., and Ellis, B. J. (2005).
Biological sensitivity to context:
I. An evolutionary-developmental
theory of the origins and func-
tions of stress reactivity. Dev.
Psychopathol. 17, 271–301. doi:
10.1017/S0954579405050145
Boyce, W. T., Essex, M. J., Woodward,
H. R., Measelle, J. R., Ablow, J.
C., and Kupfer, D. J. (2002). The
confluence of mental, physical,
social, and academic difficulties
in middle childhood. I: explor-
ing the “headwaters” of early life
morbidities. J. Am. Acad. Child
Adolesc. Psychiatry 41, 580–587.
doi: 10.1097/00004583-200205000-
00016
Boyle, M. H., Offord, D. R., Racine,
Y., Fleming, J. E., Szatmari,
P., and Sanford, M. (1993).
Evaluation of the revised
Ontario child health study scales.
J. Child Psychol. Psychiatry 34,
189–213. doi: 10.1111/j.1469-
7610.1993.tb00979.x
Braver, T. S., Cohen, J. D., and Barch,
D. M. (2002). “The role of the
prefrontal cortex in normal and
disordered cognitive control: a
cognitive neuroscience perspec-
tive,” in Principles of Frontal Lobe
Function, eds D. T. Stuss and R. T.
Knight (Oxford, England: Oxford
University Press), 428–448.
Brigman, J. L., Mathur, P., Harvey-
White, J., Izquierdo, A., Saksida,
L. M., Bussey, T. J., et al. (2010).
Pharmacological or genetic inacti-
vation of the serotonin transporter
improves reversal learning in mice.
Cereb. Cortex 20, 1955–1963. doi:
10.1093/cercor/bhp266
Bull, R., and Scerif, G. (2001).
Executive functioning as a pre-
dictor of children’s mathematics
ability: Inhibition, switching,
Frontiers in Cellular Neuroscience www.frontiersin.org October 2013 | Volume 7 | Article 180 | 9
Weikum et al. Prenatal SRI exposure and executive function
and working memory. Dev.
Neuropsychol. 19, 273–293. doi:
10.1207/S15326942DN1903_3
Buss, C., Davis, E., Hobel, C., and
Sandman, C. (2011). Maternal
pregnancy-specific anxiety is asso-
ciated with child executive function
at 6-9 years age. Stress 14, 665–676.
Canli, T., Omura, K., Haas, B. W.,
Fallgatter, A., Constable, R. T., and
Lesch, K. P. (2005). Beyond affect:
a role for genetic variation of
the serotonin transporter in neu-
ral activation during a cognitive
attention task. Proc. Natl. Acad.
Sci. U.S.A. 102, 12224–12229. doi:
10.1073/pnas.0503880102
Carlson, S. M. (2003). Executive
function in context: development,
measurement, theory, and experi-
ence. Monogr. Soc. Res. Child Dev.
68, 138–151. doi: 10.1111/j.1540-
5834.2003.06803012.x
Caspi, A., and Moffitt, T. E. (2006).
Gene–environment interactions in
psychiatry: joining forces with neu-
roscience. Nat. Rev. Neurosci. 7,
583–590. doi: 10.1038/nrn1925
Caspi, A., Sugden, K., Moffitt, T. E.,
Taylor, A., Craig, I. W., Harrington,
H., et al. (2003). Influence of life
stress on depression: moderation
by a polymorphism in the 5-HTT
gene. Science 301, 386–389. doi:
10.1126/science.1083968
Champod, A. S., and Petrides, M.
(2007). Dissociable roles of the pos-
terior parietal and the prefrontal
cortex in manipulation and mon-
itoring processes. Proc. Natl. Acad.
Sci. U.S.A. 104, 14837–14842. doi:
10.1073/pnas.0607101104
Clarke, H., Walker, S., Dalley, J.,
Robbins, T., and Roberts, A. (2007).
Cognitive inflexibility after pre-
frontal serotonin depletion is behav-
iorally and neurochemically spe-
cific. Cereb. Cortex 17, 18–27. doi:
10.1093/cercor/bhj120
Cooper, W. O., Willy, M. E., Pont,
S. J., and Ray, W. A. (2007).
Increasing use of antidepres-
sants in pregnancy. Am. J. Obstet.
Gynecol. 196, 544.e1–544.e5. doi:
10.1016/j.ajog.2007.01.033
Davidson, M. C., Amso, D., Anderson,
L. C., and Diamond, A. (2006).
Development of cognitive con-
trol and executive functions
from 4 to 13 years: evidence
from manipulations of memory,
inhibition, and task switch-
ing. Neuropsychologia 44, 2037.
doi: 10.1016/j.neuropsychologia.
2006.02.006
Davis, E. P., Buss, C., Muftuler, L.
T., Head, K., Hasso, A., Wing, D.
A., et al. (2011). Children’s brain
development benefits from longer
gestation. Front. Psychol. 2, 1–7. doi:
10.3389/fpsyg.2011.00001
Diamond, A. (2011). Biological and
social influences on cognitive con-
trol processes dependent on pre-
frontal cortex. Prog. Brain Res. 189,
319–339. doi: 10.1016/B978-0-444-
53884-0.00032-4
Diamond, A. (2013). Executive
Functions. Annu. Rev. Psychol. 64,
135–168. doi: 10.1146/annurev-
psych-113011-143750
Diamond, A., Barnett, W. S., Thomas,
J., and Munro, S. (2007). Preschool
program improves cognitive con-
trol. Science 318, 1387–1388. doi:
10.1126/science.1151148
DiPietro, J. A., Novak, M. F. S. X.,
Costigan, K. A., Atella, L. D., and
Reusing, S. P. (2006). Maternal
psychological distress during preg-
nancy in relation to child devel-
opment at age two. Child Dev.
77, 573–587. doi: 10.1111/j.1467-
8624.2006.00891.x
Elgar, F. J., McGrath, P. J., Waschbusch,
D. A., Stewart, S. H., and Curtis,
L. J. (2004). Mutual influences
on maternal depression and
child adjustment problems. Clin.
Psychol. Rev. 24, 441–459. doi:
10.1016/j.cpr.2004.02.002
Ellis, B. J., Boyce, W. T., Belsky, J.,
and Bakermans-Kranenburg, M.
J. (2011). Differential suscep-
tibility to the environment: an
evolutionary-neurodevelopmental
theory.Dev. Psychopathol. 23, 7. doi:
10.1017/S0954579410000611
Enge, S., Fleischhauer, M., Lesch, K.
P., Reif, A., and Strobel, A. (2011).
Serotonergic modulation in exec-
utive functioning: linking genetic
variations to working memory
performance. Neuropsychologia
49, 3776–3785. doi: 10.1016/j.
neuropsychologia.2011.09.038
Espy, K. A., Kaufmann, P. M.,
and Glisky, M. L. (1999).
Neuropsychologic function in
toddlers exposed to cocaine in
utero: a preliminary study. Dev.
Neuropsychol. 15, 447–460. doi:
10.1080/87565649909540761
Essex, M. J., Boyce, W. T., Goldstein,
L. H., Armstrong, J. M., Kraemer,
H. C., and Kupfer, D. J. (2002).
The confluence of mental, physi-
cal, social, and academic difficulties
in middle childhood. II: developing
the macarthur health and behavior
questionnaire. J. Am. Acad. Child
Adolesc. Psychiatry 41, 588–603.
doi: 10.1097/00004583-200205000-
00017
Essex, M. J., Kraemer, H. C.,
Armstrong, J. M., Boyce, W. T.,
Goldsmith, H. H., Klein, M. H.,
et al. (2006). Exploring risk factors
for the emergence of children’s
mental health problems. Arch. Gen.
Psychiatry 63, 1246–1256. doi:
10.1001/archpsyc.63.11.1246
Evers, E., Van der Veen, F., Jolles,
J., Deutz, N., and Schmitt, J.
(2006). Acute tryptophan depletion
improves performance and mod-
ulates the BOLD response during
a Stroop task in healthy females.
Neuroimage 32, 248–255. doi:
10.1016/j.neuroimage.2006.03.026
Fox, S. E., Levitt, P., and Nelson, C. A.
(2010). How the timing and qual-
ity of early experiences influence
the development of brain architec-
ture. Child Dev. 81, 28–40. doi:
10.1111/j.1467-8624.2009.01380.x
Gaspar, P., Cases, O., and Maroteaux,
L. (2003). The developmental role of
serotonin: news frommouse molec-
ular genetics. Nat. Rev. Neurosci. 4,
1002–1012. doi: 10.1038/nrn1256
Gathercole, S. E., Tiffany, C.,
Briscoe, J., and Thorn, A. (2005).
Developmental consequences of
poor phonological short-term
memory function in childhood:
a longitudinal study. J. Child
Psychol. Psychiatry 46, 598–611. doi:
10.1111/j.1469-7610.2004.00379.x
Gelfand, D. M., and Teti, D. M. (1990).
The effects of maternal depres-
sion on children. Clin. Psychol. Rev.
10, 329–353. doi: 10.1016/0272-
7358(90)90065-I
Gizer, I. R., Ficks, C., and Waldman, I.
D. (2009). Candidate gene studies
of ADHD: a meta-analytic review.
Hum. Genet. 126, 51–90. doi:
10.1007/s00439-009-0694-x
Goldman, D., Oroszi, G., and Ducci,
F. (2005). The genetics of addic-
tions: uncovering the genes.
Nat. Rev. Genet. 6, 521–532. doi:
10.1038/nrg1635
Goodman, S. H., and Gotlib, I. H.
(1999). Risk for psychopathology in
the children of depressed mothers:
a developmental model for under-
standing mechanisms of transmis-
sion. Psychol. Rev. 106, 458. doi:
10.1037/0033-295X.106.3.458
Gross, H. E., Shaw, D. S., Moilanen, K.
L., Dishion, T. J., and Wilson, M. N.
(2008). Reciprocal models of child
behavior and depressive symptoms
in mothers and fathers in a sample
of children at risk for early con-
duct problems. J. Fam. 22, 742. doi:
10.1037/a0013514
Hamilton, M. (1960). A rating
scale for depression. J. Neurol.
Neurosurg. Psychiatr. 23, 56–62. doi:
10.1136/jnnp.23.1.56
Hanley, G. E., and Oberlander, T. F.
(2012). Neurodevelopmental out-
comes following prenatal expo-
sure to serotonin reuptake inhibitor
antidepressants: a “social terato-
gen” or moderator of developmen-
tal risk? Birth Defects Res. A 94,
651–659. doi: 10.1002/bdra.23032
Harmer, C. J., Bhagwagar, Z., Cowen,
P. J., and Goodwin, G. M. (2002).
Acute administration of citalopram
facilitates memory consoli-
dation in healthy volunteers.
Psychopharmacology 163, 106–110.
doi: 10.1007/s00213-002-1151-x
Heils, A., Teufel, A., Petri, S., Stöber,
G., Riederer, P., Bengel, D.,
et al. (1996). Allelic variation
of human serotonin transporter
gene expression. J. Neurochem. 66,
2621–2624. doi: 10.1046/j.1471-
4159.1996.66062621.x
Hensler, J. G. (2006). Serotonergic
modulation of the limbic sys-
tem. Neurosci. Biobehav. Rev. 30,
203–214. doi: 10.1016/j.neubiorev.
2005.06.007
Homberg, J. R., and Lesch, K. P. (2011).
Looking on the bright side of sero-
tonin transporter gene variation.
Biol. Psychiatry 69, 513–519. doi:
10.1016/j.biopsych.2010.09.024
Homberg, J., Olivier, J., Smits, B.,
Mul, J., Mudde, J., Verheul, M.,
et al. (2007a). Characterization of
the serotonin transporter knockout
rat: a selective change in the func-
tioning of the serotonergic system.
Neuroscience 146, 1662–1676. doi:
10.1016/j.neuroscience.2007.03.030
Homberg, J. R., Pattij, T., Janssen, M.
C., Ronken, E., De Boer, S. F.,
Schoffelmeer, A. N., et al. (2007b).
Serotonin transporter deficiency in
rats improves inhibitory control
but not behavioural flexibility. Eur.
J. Neurosci. 26, 2066–2073. doi:
10.1111/j.1460-9568.2007.05839.x
Homberg, J. R., Schubert, D.,
and Gaspar, P. (2010). New
perspectives on the neurodevel-
opmental effects of SSRIs. Trends
Pharmacol. Sci. 31, 60–65. doi:
10.1016/j.tips.2009.11.003
Hughes, C., Roman, G., Hart, M.
J., and Ensor, R. (2013). Does
maternal depression predict young
children’s executive function?–a 4-
year longitudinal study. J. Child
Psychol. Psychiatry 54, 169–177. doi:
10.1111/jcpp.12014
Hughes, C. H., and Ensor, R. A. (2009).
How do families help or hinder the
emergence of early executive func-
tion? New Dir. Child Adolesc. Dev.
2009, 35–50. doi: 10.1002/cd.234
Jedema, H. P., Gianaros, P. J., Greer,
P. J., Kerr, D. D., Liu, S., Higley,
J. D., et al. (2009). Cognitive
impact of genetic variation of the
serotonin transporter in primates
is associated with differences in
brain morphology rather than
Frontiers in Cellular Neuroscience www.frontiersin.org October 2013 | Volume 7 | Article 180 | 10
Weikum et al. Prenatal SRI exposure and executive function
serotonin neurotransmission.
Mol. Psychiatry 15, 512–522. doi:
10.1038/mp.2009.90
Kail, R., and Salthouse, T. A. (1994).
Processing speed as a mental capac-
ity. Acta Psychol. 86, 199–225. doi:
10.1016/0001-6918(94)90003-5
Kalueff, A., Olivier, J., Nonkes, L.,
and Homberg, J. (2010). Conserved
role for the serotonin transporter
gene in rat and mouse neurobe-
havioral endophenotypes. Neurosci.
Biobehav. Rev. 34, 373–386. doi:
10.1016/j.neubiorev.2009.08.003
Kendler, K. S., Kuhn, J. W., Vittum, J.,
Prescott, C. A., and Riley, B. (2005).
The interaction of stressful life
events and a serotonin transporter
polymorphism in the prediction of
episodes of major depression: a
replication. Arch. Gen. Psychiatry
62, 529–535. doi: 10.1001/arch-
psyc.62.5.529
Kim, J., Riggs, K. W., Misri, S., Kent,
N., Oberlander, T. F., Grunau, R. E.,
et al. (2006). Stereoselective dispo-
sition of fluoxetine and norfluoxe-
tine during pregnancy and breast-
feeding. Br. J. Clin. Pharmacol.
61, 155–163. doi: 10.1111/j.1365-
2125.2005.02538.x
King, M. V., Marsden, C. A., and Fone,
K. C. (2008). A role for the 5-
HT1A, 5-HT 4 and 5-HT6 recep-
tors in learning and memory. Trends
Pharmacol. Sci. 29, 482–492. doi:
10.1016/j.tips.2008.07.001
Kolb, B., Gibb, R., and Robinson, T. E.
(2003). Brain plasticity and behav-
ior. Curr. Dir. Psychol. 12, 1–5. doi:
10.1111/1467-8721.01210
Laine, K., Heikkinen, T., Ekblad, U.,
and Kero, P. (2003). Effects of expo-
sure to selective serotonin reup-
take inhibitors during pregnancy
on serotonergic symptoms in new-
borns and cord blood monoamine
and prolactin concentrations. Arch.
Gen. Psychiatry 60, 720–726. doi:
10.1001/archpsyc.60.7.720
Lee, L., and Lee, L. J. (2012). Neonatal
fluoxetine exposure alters motor
performances of adolescent rats.
Dev. Neurobiol. 72, 1122–1132. doi:
10.1002/dneu.20942
Lemery-Chalfant, K., Schreiber, J.
E., Schmidt, N. L., Van Hulle, C.
A., Essex, M. J., and Goldsmith,
H. (2007). Assessing internaliz-
ing, externalizing, and attention
problems in young children:
validation of the MacArthur
HBQ. J. Am. Acad. Child Adolesc.
Psychiatry 46, 1315–1323. doi:
10.1097/chi.0b013e3180f616c6
Lesch, K. (2007). Linking emo-
tion to the social brain.
EMBO Rep. 8, S24–S29. doi:
10.1038/sj.embor.7401008
Lesch, K., Bengel, D., Heils, A.,
Sabol, S. Z., Greenberg, B. D.,
Petri, S., et al. (1996). Association
of anxiety-related traits with a
polymorphism in the serotonin
transporter gene regulatory region.
Science 274, 1527–1531. doi:
10.1126/science.274.5292.1527
Lesch, K., Wolozin, B., Estler, H.,
Murphy, D., and Riederer, P. (1993).
Isolation of a cDNA encoding the
human brain serotonin transporter.
J. Neural Transm. 91, 67–72. doi:
10.1007/BF01244919
Liao, C., and Lee, L. (2011). Neonatal
fluoxetine exposure affects the
action potential properties and
dendritic development in cor-
tical subplate neurons of rats.
Toxicol. Lett. 207, 314–321. doi:
10.1016/j.toxlet.2011.09.028
Lira, A., Zhou, M., Castanon, N.,
Ansorge, M. S., Gordon, J. A.,
Francis, J. H., et al. (2003). Altered
depression-related behaviors and
functional changes in the dor-
sal raphe nucleus of serotonin
transporter-deficient mice. Biol.
Psychiatry 54, 960–971. doi:
10.1016/S0006-3223(03)00696-6
Luby, J. L., Heffelfinger, A., Measelle, J.
R., Ablow, J. C., Essex,M. J., Dierker,
L., et al. (2002). Differential per-
formance of the MacArthur HBQ
and DISC-IV in identifying DSM-
IV internalizing psychopathology in
young children. J. Am. Acad. Child
Adolesc. Psychiatry 41, 458–466.
doi: 10.1097/00004583-200204000-
00019
Mannie, Z., Barnes, J., Bristow,
G., Harmer, C., and Cowen, P.
(2009). Memory impairment
in young women at increased
risk of depression: influence of
cortisol and 5-HTT genotype.
Psychol. Med. 39, 757–762. doi:
10.1017/S0033291708004248
Miller, E. K., and Cohen, J. D. (2001).
An integrative theory of pre-
frontal cortex function. Annu.
Rev. Neurosci. 24, 167–202. doi:
10.1146/annurev.neuro.24.1.167
Miyake, A., Friedman, N. P., Emerson,
M. J., Witzki, A. H., Howerter, A.,
and Wager, T. D. (2000). The unity
and diversity of executive functions
and their contributions to complex
“frontal lobe” tasks: a latent variable
analysis. Cognit. Psychol. 41, 49–100.
doi: 10.1006/cogp.1999.0734
Moffitt, T. E., Arseneault, L., Belsky,
D., Dickson, N., Hancox, R. J.,
Harrington, H., et al. (2011).
A gradient of childhood self-
control predicts health, wealth,
and public safety. Proc. Natl. Acad.
Sci. U.S.A. 108, 2693–2698. doi:
10.1073/pnas.1010076108
Moffitt, T. E., Caspi, A., and Rutter,
M. (2005). Strategy for investigat-
ing interactions between measured
genes and measured environments.
Arch. Gen. Psychiatry 62, 473–481.
doi: 10.1001/archpsyc.62.5.473
Moses-Kolko, E. L., Bogen, D., Perel,
J., Bregar, A., Uhl, K., Levin, B.,
et al. (2005). Neonatal signs after
late in utero exposure to sero-
tonin reuptake inhibitors. J. Am.
Med. Assoc. 293, 2372–2383. doi:
10.1001/jama.293.19.2372
Mulder, E. J., Ververs, F. F., de Heus,
R., and Visser, G. H. (2011).
Selective serotonin reuptake
inhibitors affect neurobehavioral
development in the human fetus.
Neuropsychopharmacology 36,
1961–1971. doi: 10.1038/npp.
2011.67
Munafò, M. R., Durrant, C., Lewis,
G., and Flint, J. (2009). Gene×
environment interactions at the
serotonin transporter locus. Biol.
Psychiatry 65, 211–219. doi:
10.1016/j.biopsych.2008.06.009
Nonkes, L. J., Tomson, K., Mærtin, A.,
Dederen, J., Roald Maes, J., and
Homberg, J. (2010). Orbitofrontal
cortex and amygdalar over-activity
is associated with an inability to
use the value of expected out-
comes to guide behaviour in
serotonin transporter knockout
rats. Neurobiol. Learn. Mem. 94,
65–72. doi: 10.1016/j.nlm.2010.
04.002
Nonkes, L. J., van de Vondervoort,
I. I., de Leeuw, M. J., Wijlaars,
L. P., Maes, J. H., and Homberg,
J. R. (2012). Serotonin trans-
porter knockout rats show
improved strategy set-shifting
and reduced latent inhibition.
Learn. Mem. 19, 190–193. doi:
10.1101/lm.025908.112
Nulman, I., Rovet, J., Stewart, D.
E., Wolpin, J., Pace-Asciak, P.,
Shuhaiber, S., et al. (2002). Child
development following exposure
to tricyclic antidepressants or
fluoxetine throughout fetal life: a
prospective, controlled study. Am.
J. Psychiatry 159, 1889–1895. doi:
10.1176/appi.ajp.159.11.1889
Oberlander, T., Gingrich, J., and
Ansorge, M. (2009). Sustained
neurobehavioral effects of exposure
to SSRI antidepressants during
development: molecular to clinical
evidence. Clin. Pharmacol. Ther. 86,
672–677. doi: 10.1038/clpt.2009.201
Oberlander, T. F., Grunau, R. E.,
Fitzgerald, C., Ellwood, A. L.,
Misri, S., Rurak, D., et al. (2002).
Prolonged prenatal psychotropic
medication exposure alters neonatal
acute pain response. Pediatr. Res. 51,
443–453. doi: 10.1203/00006450-
200204000-00008
Oberlander, T. F., Grunau, R. E.,
Fitzgerald, C., Papsdorf, M., Rurak,
D., and Riggs, W. (2005). Pain
reactivity in 2-month-old infants
after prenatal and postnatal selec-
tive serotonin reuptake inhibitor
medication exposure. Pediatrics 115,
411–425. doi: 10.1542/peds.2004-
0420
Oberlander, T. F., Papsdorf, M., Brain,
U. M., Misri, S., Ross, C., and
Grunau, R. E. (2010). Prenatal
effects of selective serotonin reup-
take inhibitor antidepressants, sero-
tonin transporter promoter geno-
type (SLC6A4), and maternal mood
on child behavior at 3 years of
age. Arch. Pediatr. Adolesc. Med.
164, 444–451. doi: 10.1001/archpe-
diatrics.2010.51
Olivier, J., Blom, T., Arentsen, T.,
and Homberg, J. (2011). The
age-dependent effects of selective
serotonin reuptake inhibitors in
humans and rodents: a review.
Prog. Neuro. Psychopharmacol. Biol.
Psychiatry 35, 1400–1408. doi:
10.1016/j.pnpbp.2010.09.013
Owens, M., Goodyer, I. M., Wilkinson,
P., Bhardwaj, A., Abbott, R.,
Croudace, T., et al. (2012). 5-
HTTLPR and early childhood
adversities moderate cognitive and
emotional processing in adoles-
cence. PLoS ONE 7:e48482. doi:
10.1371/journal.pone.0048482
Petrides, M. (2005). Lateral prefrontal
cortex: architectonic and functional
organization. Philos. Trans. R. Soc.
B Biol. Sci. 360, 781–795. doi:
10.1098/rstb.2005.1631
Popa, D., Léna, C., Alexandre, C.,
and Adrien, J. (2008). Lasting syn-
drome of depression produced by
reduction in serotonin uptake dur-
ing postnatal development: evi-
dence from sleep, stress, and behav-
ior. J. Neurosci. 28, 3546. doi:
10.1523/JNEUROSCI.4006-07.2008
Preece, M., Dalley, J., Theobald, D.,
Robbins, T., and Reynolds, G.
(2004). Region specific changes
in forebrain 5-hydroxytryptamine
1a and 5-hydroxytryptamine 2a
receptors in isolation-reared rats:
an in vitro autoradiography study.
Neuroscience 123, 725–732. doi:
10.1016/j.neuroscience.2003.10.008
Reuter, M., Ott, U., Vaitl, D., and
Hennig, J. (2007). Impaired exec-
utive control is associated with a
variation in the promoter region of
the tryptophan hydroxylase 2 gene.
J. Cogn. Neurosci. 19, 401–408. doi:
10.1162/jocn.2007.19.3.401
Riedel, W. J., Eikmans, K., Heldens,
A., and Schmitt, J. A. J. (2005).
Frontiers in Cellular Neuroscience www.frontiersin.org October 2013 | Volume 7 | Article 180 | 11
Weikum et al. Prenatal SRI exposure and executive function
Specific serotonergic reuptake
inhibition impairs vigilance
performance acutely and
after subchronic treatment.
J. Psychopharmacology 19, 12–20.
doi: 10.1177/0269881105048887
Riggs, N. R., Blair, C. B., and
Greenberg, M. T. (2004).
Concurrent and 2-year longitu-
dinal relations between executive
function and the behavior of 1st
and 2nd grade children. Child
Neuropsychol. 9, 267–276. doi:
10.1076/chin.9.4.267.23513
Risch, N., Herrell, R., Lehner, T.,
Liang, K., Eaves, L., Hoh, J., et al.
(2009). Interaction between the
serotonin transporter gene (5-
HTTLPR), stressful life events,
and risk of depression. J. Am.
Med. Assoc. 301, 2462–2471. doi:
10.1001/jama.2009.878
Roiser, J. (2011). Bridging the
gap between genes and
behaviour: the case for neu-
roimaging genetics. J. Neurol.
Neurosurg. Psychiatry 82, e2. doi:
10.1136/jnnp-2011-300504.24
Roiser, J. P., Blackwell, A. D., Cools,
R., Clark, L., Rubinsztein, D. C.,
Robbins, T. W., et al. (2006).
Serotonin transporter polymor-
phism mediates vulnerability to
loss of incentive motivation fol-
lowing acute tryptophan depletion.
Neuropsychopharmacology 31,
2264–2272. doi: 10.1038/sj.npp.
1301084
Roiser, J. P., Müller, U., Clark, L.,
and Sahakian, B. J. (2007). The
effects of acute tryptophan deple-
tion and serotonin transporter poly-
morphism on emotional process-
ing in memory and attention. Int.
J. Neuropsychopharmacol. 10, 449.
doi: 10.1017/S146114570600705X
Salisbury, A. L., Ponder, K. L., Padbury,
J. F., and Lester, B. M. (2009).
Fetal effects of psychoactive drugs.
Clin. Perinatol. 36, 595. doi:
10.1016/j.clp.2009.06.002
Sasaki-Adams, D. M., and Kelley, A. E.
(2001). Serotonin-dopamine inter-
actions in the control of condi-
tioned reinforcement and motor
behavior. Neuropsychopharmacology
25, 440–452. doi: 10.1016/S0893-
133X(01)00240-8
Schmitt, J. A., Kruizinga, M. J.,
and Riedel, W. J. (2001).
Non-serotonergic pharmaco-
logical profiles and associated
cognitive effects of sero-
tonin reuptake inhibitors.
J. Psychopharmacol. 15, 173–179.
doi: 10.1177/026988110101500304
Schmitt, J. A. J., Jorissen, B. L.,
Sobczak, S., van Boxtel, M. P. J.,
Hogervorst, E., Deutz, N. E. P.,
et al. (2000). Tryptophan deple-
tion impairs memory consolida-
tion but improves focussed atten-
tion in healthy young volunteers.
J. Psychopharmacol. 14, 21–29. doi:
10.1177/026988110001400102
Schmitt, J. A. J., Wingen, M.,
Ramaekers, J. G., Evers, E. A. T.,
and Riedel, W. J. (2006). Serotonin
and human cognitive performance.
Curr. Pharm. Des. 12, 2473–2486.
doi: 10.2174/138161206777698909
Schonfeld, A. M., Paley, B., Frankel,
F., and O’Connor, M. J. (2006).
Executive functioning predicts
social skills following prena-
tal alcohol exposure. Child
Neuropsychol. 12, 439–452. doi:
10.1080/09297040600611338
Schruers, K., Esquivel, G., van Duinen,
M., Wichers, M., Kenis, G.,
Colasanti, A., et al. (2011). Genetic
moderation of CO2-induced
fear by 5-HTTLPR genotype.
J. Psychopharmacol. 25, 37–42. doi:
10.1177/0269881110372543
Shirtcliff, E. A., and Essex, M. J. (2008).
Concurrent and longitudinal asso-
ciations of basal and diurnal cortisol
with mental health symptoms in
early adolescence. Dev. Psychobiol.
50, 690–703. doi: 10.1002/dev.
20336
Siepmann, M., Grossmann, J., Mück-
Weymann, M., and Kirch, W.
(2003). Effects of sertraline
on autonomic and cognitive
functions in healthy volunteers.
Psychopharmacology (Berl.) 168,
293–298. doi: 10.1007/s00213-003-
1448-4
Simpson, K. L., Weaver, K. J., de Villers-
Sidani, E., Lu, J. Y., Cai, Z., Pang,
Y., et al. (2011). Perinatal antide-
pressant exposure alters cortical net-
work function in rodents. Proc. Natl.
Acad. Sci. U.S.A. 108, 18465–18470.
doi: 10.1073/pnas.1109353108
Strobel, A., Dreisbach, G., Müller,
J., Goschke, T., Brocke, B., and
Lesch, K. P. (2007). Genetic
variation of serotonin function
and cognitive control. J. Cogn.
Neurosci. 19, 1923–1931. doi:
10.1162/jocn.2007.19.12.1923
Taghavi, M. R., Neshat-Doost,
H. T., Moradi, A. R., Yule,
W., and Dalgleish, T. (1999).
Biases in visual attention in
children and adolescents with
clinical anxiety and mixed
anxiety-depression. J. Abnorm.
Child Psychol. 27, 215–223. doi:
10.1023/A:1021952407074
Taylor, S. E., Way, B. M., Welch, W.
T., Hilmert, C. J., Lehman, B. J.,
and Eisenberger, N. I. (2006).
Early family environment, current
adversity, the serotonin trans-
porter promoter polymorphism,
and depressive symptomatology.
Biol. Psychiatry 60, 671–676. doi:
10.1016/j.biopsych.2006.04.019
Valluzzi, J. A., and Chan, K. H.
(2007). Effects of fluoxetine
on hippocampal-dependent
and hippocampal-independent
learning tasks. Behav.
Pharmacol. 18, 507–513. doi:
10.1097/FBP.0b013e3282ee2a91
van Ijzendoorn, M. H., Belsky, J.,
and Bakermans-Kranenburg, M.
J. (2012). Serotonin transporter
genotype 5HTTLPR as a marker
of differential susceptibility? A
meta-analysis of child and adoles-
cent gene-by-environment studies.
Transl. Psychiatry 2:e147. doi:
10.1038/tp.2012.73
Varnäs, K., Halldin, C., and Hall, H.
(2004). Autoradiographic distribu-
tion of serotonin transporters and
receptor subtypes in human brain.
Hum. Brain Mapp. 22, 246–260. doi:
10.1002/hbm.20035
Weikum, W. M., Oberlander, T. F.,
Hensch, T. K., and Werker, J.
F. (2012). Prenatal exposure to
antidepressants and depressed
maternal mood alter trajectory
of infant speech perception.
Proc. Natl. Acad. Sci. U.S.A. 109,
17221–17227. doi: 10.1073/pnas.
1121263109
Zanto, T. P., Rubens, M. T., Thangavel,
A., and Gazzaley, A. (2011). Causal
role of the prefrontal cortex in
top-down modulation of visual
processing and working memory.
Nat. Neurosci. 14, 656–661. doi:
10.1038/nn.2773
Zheng, J., Xu, D., Li, K., Wang, H.,
Shen, P., Lin, M., et al. (2011).
Neonatal exposure to fluoxetine and
fluvoxamine alteres spine density in
mouse hippocampal CA1 pyrami-
dal neurons. Int. J. Clin. Exp. Pathol.
4, 162.
Conflict of Interest Statement: The
authors declare that the research
was conducted in the absence of any
commercial or financial relationships
that could be construed as a potential
conflict of interest.
Received: 19 July 2013; accepted: 24
September 2013; published online: 11
October 2013.
Citation: Weikum WM, Brain U,
Chau CMY, Grunau RE, Boyce WT,
Diamond A and Oberlander TF (2013)
Prenatal serotonin reuptake inhibitor
(SRI) antidepressant exposure and
serotonin transporter promoter genotype
(SLC6A4) influence executive functions
at 6 years of age. Front. Cell. Neurosci.
7:180. doi: 10.3389/fncel.2013.00180
This article was submitted to the journal
Frontiers in Cellular Neuroscience.
Copyright © 2013 Weikum, Brain,
Chau, Grunau, Boyce, Diamond and
Oberlander. This is an open-access arti-
cle distributed under the terms of the
Creative Commons Attribution License
(CC BY). The use, distribution or repro-
duction in other forums is permitted,
provided the original author(s) or licen-
sor are credited and that the original
publication in this journal is cited, in
accordance with accepted academic prac-
tice. No use, distribution or reproduction
is permitted which does not comply with
these terms.
Frontiers in Cellular Neuroscience www.frontiersin.org October 2013 | Volume 7 | Article 180 | 12
